Table 2. MicroRNAs implicated in congenital heart disease.
MicroRNA | Species | Congenital heart defect | References |
---|---|---|---|
miR-133a-1/miR-1-2; miR-133a-2/miR-1-1 | Mice | VSD, chamber dilatation | Zhao et al. (8); Liu et al. (34), Catalucci et al. (9) |
miR-1-1/miR-181c | Human cardiac tissue | VSD | Li et al. (35) |
miR-92 | Mouse embryos | VSD | Catalucci et al. (9) |
miR-17-92 cluster | Mice | VSD | Ventura et al. (36) |
19b, 29c | Human maternal blood | VSD | Zhu et al. (37) |
let-7e-5p, miR-155-5p, miR-222-3p, miR-379-5p, miR-409-3p, miR-433, miR-487b | Human plasma | VSD | Li et al. (38) |
miR-196 | Foetal human heart samples | Cardiac septation, morphogenesis, valve formatio | Goddeeris et al. (39) |
miR-99a, let-7c, miR-125b-b, miR-155, miR-802 | Human DNA | Down Syndrome | Latronico et al. (40) |
miR-19b, miR-22, miR-29c, miR -375, miR -421 | Human maternal blood | TOF | Zhu et al. (37), O’Brien et al. (41) |
miR-26a, miR-95, miR-30b and miR-141 | Human aortic valves; porcine valvular interstitial cells | BAV | Nigram et al. (42); Yanagawn et al. (43) |
List of microRNAs implicated in congenital heart disease (CHD). miR, microRNA; VSD, ventricular septal defect; TOF, tetralogy of Fallot; BAV, bicuspid aortic valve.